Difference between revisions
malaria-vaccine
Status and infobox
- status:
—→ partial - kind:
—→ problem - year:
—→ 1967 - statement:
—→ Can a vaccine prevent malaria at high efficacy?
Source +17 −0
+---
+title: A malaria vaccine
+kind: problem
+status: partial
+year: 1967
+statement: Can a vaccine prevent malaria at high efficacy?
+space: infectious-disease
+---
+Parasites are far harder to vaccinate against than viruses. The first two recommended vaccines cut clinical cases substantially in young children, with R21 showing about 75% efficacy in trials. Durable, high protection for everyone remains the goal.
+
+Closed 2021 RTS,S and 2023 R21 recommended by WHO.
+
+## Sources
+
+- [Wikipedia: Malaria vaccine](https://en.wikipedia.org/wiki/Malaria_vaccine)
+
+[[Space:infectious-disease|Infectious disease]] · [[Continent:medicine|Medicine]]
Revision 183 as rendered
Parasites are far harder to vaccinate against than viruses. The first two recommended vaccines cut clinical cases substantially in young children, with R21 showing about 75% efficacy in trials. Durable, high protection for everyone remains the goal.
Closed 2021 RTS,S and 2023 R21 recommended by WHO.